These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 10700237

  • 21. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F, Genetel N, Rioux-Leclercq N, Bansard JY, Levêque J, Guillé F, Patard JJ, Lesimple T, Catros-Quemener V.
    Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
    [Abstract] [Full Text] [Related]

  • 22. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
    Chagnon F, Tanguay S, Ozdal OL, Guan M, Ozen ZZ, Ripeau JS, Chevrette M, Elhilali MM, Thompson-Snipes LA.
    Clin Cancer Res; 2005 Feb 01; 11(3):1302-11. PubMed ID: 15709202
    [Abstract] [Full Text] [Related]

  • 23. Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
    Avigan D, Vasir B, Gong J, Borges V, Wu Z, Uhl L, Atkins M, Mier J, McDermott D, Smith T, Giallambardo N, Stone C, Schadt K, Dolgoff J, Tetreault JC, Villarroel M, Kufe D.
    Clin Cancer Res; 2004 Jul 15; 10(14):4699-708. PubMed ID: 15269142
    [Abstract] [Full Text] [Related]

  • 24. Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
    Galanis E, Burch PA, Richardson RL, Lewis B, Pitot HC, Frytak S, Spier C, Akporiaye ET, Peethambaram PP, Kaur JS, Okuno SH, Unni KK, Rubin J.
    Cancer; 2004 Dec 01; 101(11):2557-66. PubMed ID: 15517589
    [Abstract] [Full Text] [Related]

  • 25. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A, Tötterman TH, Böhle A, Brandau S.
    Cancer Gene Ther; 2002 Oct 01; 9(10):846-53. PubMed ID: 12224026
    [Abstract] [Full Text] [Related]

  • 26. Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses.
    Wei Y, Sticca RP, Holmes LM, Burgin KE, Li J, Williamson J, Evans L, Smith SJ, Stephenson JJ, Wagner TE.
    Int J Oncol; 2006 Mar 01; 28(3):585-93. PubMed ID: 16465362
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic dendritic cell vaccination of patients with renal cell carcinoma.
    Berntsen A, Geertsen PF, Svane IM.
    Eur Urol; 2006 Jul 01; 50(1):34-43. PubMed ID: 16675096
    [Abstract] [Full Text] [Related]

  • 28. Long-term survival of patients with metastatic renal cell carcinoma treated with pulsed dendritic cells.
    Kraemer M, Hauser S, Schmidt-Wolf IG.
    Anticancer Res; 2010 Jun 01; 30(6):2081-6. PubMed ID: 20651354
    [Abstract] [Full Text] [Related]

  • 29. Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma.
    Laurell A, Lönnemark M, Brekkan E, Magnusson A, Tolf A, Wallgren AC, Andersson B, Adamson L, Kiessling R, Karlsson-Parra A.
    J Immunother Cancer; 2017 Jun 01; 5():52. PubMed ID: 28642820
    [Abstract] [Full Text] [Related]

  • 30. [Tumor cell vaccination for treatment of renal cell carcinoma].
    Kriegmair M, Oberneder R.
    Urologe A; 1995 May 01; 34(3):204-7. PubMed ID: 7610513
    [Abstract] [Full Text] [Related]

  • 31. Dendritic cell/tumor hybrids enhances therapeutic efficacy against colorectal cancer liver metastasis in SCID mice.
    Xu F, Ye YJ, Liu W, Kong M, He Y, Wang S.
    Scand J Gastroenterol; 2010 Jun 01; 45(6):707-13. PubMed ID: 20205622
    [Abstract] [Full Text] [Related]

  • 32. Autolymphocyte therapy for metastatic renal cell carcinoma: initial clinical results from 335 patients treated in a multisite clinical practice.
    Lavin PT, Maar R, Franklin M, Ross S, Martin J, Osband ME.
    Transplant Proc; 1992 Dec 01; 24(6):3059-64. PubMed ID: 1466057
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of kidney cancer with autologous tumor cell vaccines of short-term cell lines derived from renal cell carcinoma.
    Dillman RO, Barth NM, VanderMolen LA, Garfield DH, De Leon C, O'Connor AA, Mahdavi K, Nayak SK.
    Cancer Biother Radiopharm; 2001 Feb 01; 16(1):47-54. PubMed ID: 11279797
    [Abstract] [Full Text] [Related]

  • 34. In vivo description of dendritic cells in human renal cell carcinoma.
    Schwaab T, Schned AR, Heaney JA, Cole BF, Atzpodien J, Wittke F, Ernstoff MS.
    J Urol; 1999 Aug 01; 162(2):567-73. PubMed ID: 10411089
    [Abstract] [Full Text] [Related]

  • 35. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells.
    Höltl L, Zelle-Rieser C, Gander H, Papesh C, Ramoner R, Bartsch G, Rogatsch H, Barsoum AL, Coggin JH, Thurnher M.
    Clin Cancer Res; 2002 Nov 01; 8(11):3369-76. PubMed ID: 12429623
    [Abstract] [Full Text] [Related]

  • 36. Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.
    Wang J, Liao L, Tan J.
    Immunotherapy; 2012 Oct 01; 4(10):1031-42. PubMed ID: 23148755
    [Abstract] [Full Text] [Related]

  • 37. Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.
    Barbuto JA, Ensina LF, Neves AR, Bergami-Santos P, Leite KR, Marques R, Costa F, Martins SC, Camara-Lopes LH, Buzaid AC.
    Cancer Immunol Immunother; 2004 Dec 01; 53(12):1111-8. PubMed ID: 15185011
    [Abstract] [Full Text] [Related]

  • 38. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions.
    Neves AR, Ensina LF, Anselmo LB, Leite KR, Buzaid AC, Câmara-Lopes LH, Barbuto JA.
    Cancer Immunol Immunother; 2005 Jan 01; 54(1):61-6. PubMed ID: 15693140
    [Abstract] [Full Text] [Related]

  • 39. Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma.
    Sahasrabudhe DM, deKernion JB, Pontes JE, Ryan DM, O'Donnell RW, Marquis DM, Mudholkar GS, McCune CS.
    J Biol Response Mod; 1986 Dec 01; 5(6):581-94. PubMed ID: 3491881
    [Abstract] [Full Text] [Related]

  • 40. Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide.
    Höltl L, Ramoner R, Zelle-Rieser C, Gander H, Putz T, Papesh C, Nussbaumer W, Falkensammer C, Bartsch G, Thurnher M.
    Cancer Immunol Immunother; 2005 Jul 01; 54(7):663-70. PubMed ID: 15918076
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.